HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

isocannflavin B

a phytogenic antineoplastic agent; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Flavones: 446
        isocannflavin B: 2
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Flavones: 446
        isocannflavin B: 2

Experts

1.	Erridge, Simon: 1 article (10/2020)
2.	Mangal, Nagina: 1 article (10/2020)
3.	Pacchetti, Barbara: 1 article (10/2020)
4.	Salazar, Oliver: 1 article (10/2020)
5.	Sodergren, Mikael H: 1 article (10/2020)
6.	Appendino, Giovanni: 1 article (09/2009)
7.	Bellini, Paolo: 1 article (09/2009)
8.	Brunelli, Elisa: 1 article (09/2009)
9.	Minassi, Alberto: 1 article (09/2009)
10.	Moro, Laura: 1 article (09/2009)

Related Diseases

1.	Neoplasms (Cancer) 10/01/2020 - "Outcomes were also described in preclinical models of anti-oxidation (CFL-A), anti-parasitic activity (CFL-A, CFL-C), neuroprotection (CFL-A) and cancer (Isocannflavin B, a CFL-B isomer). "
2.	Breast Neoplasms (Breast Cancer) 09/01/2009 - "The activity of 8-prenylapigenin (8-PA) and its 3'-methoxylated analogue isocannflavin B (IsoB) was investigated in estrogen-dependent T47-D and estrogen-independent MDA-MB-231 human breast cancer cell lines. "

Related Drugs and Biologics

1.	Estrogens (Estrogen)
2.	8-prenylapigenin